Pathological Responses And Heart Safety Analysis Of Trastuzumab And Paclitaxel Based Regimen Plus Carboplatin Or Epirubicin As Neoadjuvant Therapy In Clinical Stage Ii-Iii, Her2-Positive Breast Cancer Patients: A Phase 2, Open-Label, Multicentre, Randomised Trial
CANCER RESEARCH(2013)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要